DLK1 AS A PREDICTIVE MARKER FOR INSULIN RESISTANCE AND/OR TYPE 2 DIABETES AND/OR METABOLIC SYNDROME

Research output: Patent

Abstract

The present invention relates to a method for predicting the risk of developing Insulin resistance and/or type 2 diabetes and/or metabolic syndrome for a subject, based on the levels of DLK1. A determined level above a reference level is indicative of said subject being at risk of developing Insulin resistance and/or type 2 diabetes and/or metabolic syndrome and a determined level equal to or below the reference level is indicative of said subject not being currently at risk of developing Insulin resistance and/or type 2 diabetes and/or metabolic syndrome.

Original languageEnglish
IPCC12Q 1/ 6883 A I
Patent numberEP3657176
Country/TerritoryDenmark
Priority date23/11/2018
Priority numberEP20180207954
Publication statusPublished - 27. May 2020

Fingerprint

Dive into the research topics of 'DLK1 AS A PREDICTIVE MARKER FOR INSULIN RESISTANCE AND/OR TYPE 2 DIABETES AND/OR METABOLIC SYNDROME'. Together they form a unique fingerprint.

Cite this